Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-28 Sale |
2025-03-04 4:59 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
583 | $4.75 | $2,769 | 13,109 (Direct) |
View |
| 2025-02-28 Sale |
2025-03-04 4:58 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
163 | $4.76 | $776 | 7,190 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 7:15 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
372 | $4.72 | $1,756 | 13,692 (Direct) |
View |
| 2024-11-04 Sale |
2024-11-06 4:51 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
3,668 | $0.29 | $1,064 | 168,768 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-02 4:05 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
4,149 | $0.35 | $1,452 | 172,436 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-06 4:15 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
3,936 | $0.75 | $2,952 | 176,585 (Direct) |
View |
| 2024-04-05 Sale |
2024-04-09 4:22 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER |
2,753 | $0.83 | $2,285 | 53,365 (Direct) |
View |
| 2024-04-05 Sale |
2024-04-09 4:21 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
2,753 | $0.83 | $2,285 | 88,247 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 4:24 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
3,293 | $0.89 | $2,931 | 91,000 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 4:19 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
5,834 | $0.89 | $5,192 | 180,521 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 4:13 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER |
3,293 | $0.89 | $2,931 | 56,118 (Direct) |
View |
| 2023-02-08 Sale |
2024-02-12 5:16 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
7,770 | $0.53 | $4,118 | 94,293 (Direct) |
View |
| 2023-02-08 Sale |
2024-02-12 5:15 pm |
Cara Therapeutics Inc. | CARA | Maynard Ryan D CHIEF FINANCIAL OFFICER |
5,488 | $0.53 | $2,909 | 8,012 (Direct) |
View |
| 2023-02-08 Sale |
2024-02-12 5:13 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER |
7,770 | $0.53 | $4,118 | 59,411 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2031-12-15 |
Tvardi Therapeutics Inc. | TVRD | O'Brien Stephen Paul Principal Accounting Officer |
14,751 | $0 | 14,751 (Direct) |
View |
| 2025-04-15 Other |
2025-04-17 6:50 pm |
N/A N/A |
Tvardi Therapeutics Inc. | TVRD | HALL WALLACE L JR Director |
246,756 | $0 | 448,800 (Indirect) |
View |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2031-12-15 |
Tvardi Therapeutics Inc. | TVRD | Kauh John Saewook M.D. Chief Medical Officer |
74,049 | $0 | 74,049 (Direct) |
View |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2031-12-15 |
Tvardi Therapeutics Inc. | TVRD | WYZGA MICHAEL S Director |
18,441 | $0 | 18,441 (Direct) |
View |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2031-12-15 |
Tvardi Therapeutics Inc. | TVRD | Chen Yixin VP, Chem, Mfg and Ctrls |
14,752 | $0 | 14,752 (Direct) |
View |
| 2025-04-15 Other |
2025-04-17 6:50 pm |
N/A N/A |
Tvardi Therapeutics Inc. | TVRD | Wirk Shaheen Director |
439,194 | $0 | 708,560 (Indirect) |
View |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2031-01-29 |
Tvardi Therapeutics Inc. | TVRD | Wirk Shaheen Director |
6,202 | $0 | 708,560 (Direct) |
View |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2031-01-29 |
Tvardi Therapeutics Inc. | TVRD | Shah Sujal Director |
18,441 | $0 | 18,441 (Direct) |
View |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2031-01-29 |
Tvardi Therapeutics Inc. | TVRD | Larson Jeffrey Leroy SVP, Research & Development |
22,128 | $0 | 22,128 (Direct) |
View |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2032-02-03 |
Tvardi Therapeutics Inc. | TVRD | Conn Avi Daniel Chief Financial Officer |
89,053 | $0 | 89,053 (Direct) |
View |
| 2025-04-15 Option Award |
2025-04-17 6:50 pm |
N/A 2029-01-15 |
Tvardi Therapeutics Inc. | TVRD | Alibhai Imran Nizamudin Chief Executive Officer |
370,832 | $0 | 370,832 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:28 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | Boudreau Helen M Director |
345,647 | $0 | 345,647 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:26 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | von Moltke Lisa Director |
345,647 | $0 | 378,009 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:25 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
345,647 | $0 | 393,485 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:24 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | Shiff Susan Ph.D. Director |
345,647 | $0 | 397,085 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:22 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
691,295 | $0 | 801,007 (Direct) |
View |